Page last updated: 2024-10-24

chlorambucil and Palsy

chlorambucil has been researched along with Palsy in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Research Excerpts

ExcerptRelevanceReference
" (1) MISO and related compounds inhibit drug-metabolising enzymes, as measured by pentobarbitone sleep-time and zoxazolamine paralysis-time."3.66Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism. ( Lee, FY; Twentyman, PR; Walton, MI; Workman, P, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Workman, P1
Twentyman, PR1
Lee, FY1
Walton, MI1

Other Studies

1 other study available for chlorambucil and Palsy

ArticleYear
Drug metabolism and chemosensitization. Nitroimidazoles as inhibitors of drug metabolism.
    Biochemical pharmacology, 1983, Mar-01, Volume: 32, Issue:5

    Topics: Aminopyrine; Animals; Chlorambucil; Female; Kidney Function Tests; Male; Metabolic Clearance Rate; M

1983